Advances in protease inhibitors.
Cheng
B
B
D018791:CD4 Lymphocyte Count; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D015195:Drug Design; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir; D011725:Pyridines / Q000627:therapeutic use
D017320:HIV Protease Inhibitors; D011725:Pyridines; D019469:Indinavir